Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional

Efficacy Evaluation of VERU-111 for mCRPC in Patients Who Have Failed at Least One Androgen Receptor Targeting Agent

ClinicalTrials.gov ID: NCT04844749

Public ClinicalTrials.gov record NCT04844749. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 3:35 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

VERACITY - Randomized, Active-Controlled, Phase 3 Study of VERU-111 for the Treatment of Metastatic Castration-Resistant Prostate Cancer in Patients Who Have Failed Prior Treatment With at Least One Androgen Receptor Targeting Agent

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To demonstrate the efficacy of VERU-111 (Sabizabulin) in the treatment of metastatic castration-resistant prostate cancer in patients who have failed prior treatment with at least one androgen receptor targeting agent as measured by radiographic progression-free survival.

Study identification

NCT ID
NCT04844749
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Veru Inc.
Industry
Enrollment
105 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 100 Years
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 24, 2021 (Actual)
Primary completion
May 4, 2023 (Actual)
Completion
May 4, 2023 (Actual)
Last update posted
Feb 5, 2024

2021 – 2023

United States locations

U.S. sites
40
U.S. states
23
U.S. cities
39
Facility City State ZIP Site status
Alaska Oncology and Hematology, LLC. Anchorage Alaska 99508 —
Urology Associates of Southern Arizona Tucson Arizona 85715 —
Arizona Urology Specialists Tucson Arizona 85745 —
Tower Urology Los Angeles California 90048 —
University of California, Irvine Orange California 92868 —
West Coaster Center Urology Oxnard California 93036 —
San Bernardino Urological Associates San Bernardino California 92506 —
Genesis Resaerch, LLC San Diego California 92123 —
Genesis Healthcare Partners - Genesis Research Greater Los Angeles Sherman Oaks California 91411 —
Alicia Buenrostro Torrance California 90505 —
Colorado Urology Golden Colorado 80401 —
Universal Axon Clinical Research Doral Florida 33166 —
Demirra Hudge Miami Beach Florida 33140 —
Florida Urology Partners, LLC Riverview Florida 33578 —
Georgia Urology Atlanta Georgia 30309 —
Comprehensive Urologic Care Lake Barrington Illinois 60010 —
First Urology, PSC Jeffersonville Indiana 47130 —
MidAmerica Cancer Care Merriam Kansas 66204 —
Chesapeake Urology Research Associates Baltimore Maryland 21204 —
Michigan Institute of Urology Troy Michigan 48084 —
GU Research Network, LLC Omaha Nebraska 68130 —
Inpsira Medical Center Mullica Hill Mullica Hill New Jersey 08062 —
Ascension - Our Lady of Lourdes Memorial Hospital Binghamton New York 13905 —
Premier Medical Group of the Hudson Valley Poughkeepsie New York 12603 —
Associated Medical Professionals of NY, PLCC Syracuse New York 13210 —
Associated Urologists of North Carolina Raleigh North Carolina 27612 —
Cleveland Clinic Cleveland Ohio 44195 —
Clinical Research Solutions - Cleveland Middleburg Heights Ohio 44130 —
Oregon Urology Institute Springfield Oregon 97477 —
Centers for Advanced Urology, LLP MidLantic Urology Bala-Cynwyd Pennsylvania 19004 —
Carolina Urologic Research Center Myrtle Beach South Carolina 29572 —
Lexington Medical Center/ Lexington Oncology West Columbia South Carolina 29169 —
Urology Associates - Nashville Nashville Tennessee 37209 —
Houston Metro Urology Houston Texas 77027 —
Urology San Antonio P.A. San Antonio Texas 78258 —
University of Virginia Health System Charlottesville Virginia 22908 —
Virginia Urology Richmond Virginia 23230 —
Urology of Virginia, PLLC Virginia Beach Virginia 23462 —
Spokane Urology P.S. Spokane Washington 99202 —
Cancer Care Northwest Spokane Valley Washington 99216 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04844749, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 5, 2024 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04844749 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →